glp-1 receptor agonists and cancer risk in adults with obesity - UF Health Cancer Center GLP-1 Agonists For Obesity In

Injectable GLP-1RAs face limitations such as injection frequency and side effects, prompting the investigation of natural compounds that can modify GLP-1 function as alternative treatments

When food stays in your stomach longer, you feel full longer

Historical Relevance Image 5 (Source) As mentioned before, the most historically-relevant link to gila monster venom comes in the GLP-1 drug class for treatment of type-2 diabetes mellitus as well as obesity

However, new research presented in 2024 highlights a troubling link between certain GLP-1 drugs, such as Ozempic and Wegovy, and a condition known as drug-induced gastroparesis